474824-78-7 Usage
Description
3-Bromo-5-methylpyridine-2-carbonitrile is a pyridine derivative with the molecular formula C7H5BrN2. It features a bromine atom and a methyl group attached to the pyridine ring, along with a cyano group at the 2-position. This chemical compound serves as a versatile building block in organic synthesis, particularly for the preparation of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
3-Bromo-5-methylpyridine-2-carbonitrile is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the formation of more complex molecules through chemical reactions such as nucleophilic substitution and palladium-catalyzed coupling reactions. The presence of bromine and cyano groups enhances its reactivity and makes it a valuable starting material for the development of diverse heterocyclic compounds with potential therapeutic applications.
Used in Agrochemical Industry:
3-Bromo-5-methylpyridine-2-carbonitrile is also utilized as a building block in the synthesis of agrochemicals. Its ability to undergo various chemical reactions enables the creation of more complex molecules with potential applications in crop protection, pest control, and other agricultural areas. The versatility of this compound contributes to the development of innovative and effective agrochemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 474824-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,4,8,2 and 4 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 474824-78:
(8*4)+(7*7)+(6*4)+(5*8)+(4*2)+(3*4)+(2*7)+(1*8)=187
187 % 10 = 7
So 474824-78-7 is a valid CAS Registry Number.
474824-78-7Relevant articles and documents
NEW COMPOUNDS 574
-
Page/Page column 19, (2010/06/13)
The present invention relates to novel compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome,